Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care

被引:40
|
作者
Jamison, James [1 ]
Graffy, Jonathan [2 ]
Mullis, Ricky [3 ]
Mant, Jonathan [3 ]
Sutton, Stephen [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Behav Sci, Behav Sci Grp, Cambridge CB2 1TN, England
[2] Univ Cambridge, Sch Clin Med, Primary Care Unit, Inst Publ Hlth, Cambridge CB2 1TN, England
[3] Univ Cambridge, Strangeways Res Lab, Primary Care Res, Primary Care Unit, Cambridge CB2 1TN, England
来源
BRITISH JOURNAL OF GENERAL PRACTICE | 2016年 / 66卷 / 649期
关键词
general practice; medication adherence; qualitative research; secondary prevention; stroke; SURVIVORS; THERAPY; IMPACT; RISK;
D O I
10.3399/bjgp16X685609
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Medications are highly effective at reducing risk of recurrent stroke, but success is influenced by adherence to treatment. Among survivors of stroke and transient ischaemic attack (TIA), adherence to medication is known to be suboptimal. Aim To identify and report barriers to medication adherence for the secondary prevention of stroke/TIA. Design and setting A qualitative interview study was conducted within general practice surgeries in the East of England, UK. Method Patients were approached by letter and invited to take part in a qualitative research study. Semi-structured interviews were undertaken with survivors of stroke, caregivers, and GPs to explore their perspectives and views around secondary prevention and perceived barriers to medication adherence. Key themes were identified using a grounded theory approach. Verbatim quotes describing the themes are presented here. Results In total, 28 survivors of stroke, including 14 accompanying caregivers and five GPs, were interviewed. Two key themes were identified. Patient level barriers included ability to self-care, the importance people attach to a stroke event, and knowledge of stroke and medication. Medication level barriers included beliefs about medication and beliefs about how pills work, medication routines, changing medications, and regimen complexity and burden of treatment. Conclusion Patients who have had a stroke are faced with multiple barriers to taking secondary prevention medications in UK general practice. This research suggests that a collaborative approach between caregivers, survivors, and healthcare professionals is needed to address these barriers and facilitate medication-taking behaviour.
引用
收藏
页码:E568 / E576
页数:9
相关论文
共 50 条
  • [21] EXACTLY WHAT IT SAYS ON THE TIN? A QUALITATIVE STUDY ON MEDICATION ADHERENCE FOR RESISTANT HYPERTENSION IN PRIMARY CARE
    Durand, Hannah
    Casey, Monica
    Hayes, Peter
    Murphy, Andrew
    Molloy, Gerry
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2018, 25 : S190 - S191
  • [22] Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study
    Koh, Joel Jun Kai
    Cheng, Rui Xiang
    Yap, Yicheng
    Haldane, Victoria
    Tan, Yao Guo
    Teo, Krichelle Wei Qi
    Srivastava, Aastha
    Ong, Pei Shi
    Perel, Pablo
    Legido-Quigley, Helena
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 2481 - 2498
  • [23] Barriers to suicide prevention in primary care: A qualitative study among general practitioners in Germany
    Mayer, Lea
    Barzel, Anne
    Clemens, Vera
    Fegert, Jorg
    Grau, Katharina
    Guendel, Harald
    Haun, Maria
    Lamp, Natalie
    Rassenhofer, Miriam
    Rothermund, Eva
    Oexle, Nathalie
    MENTAL HEALTH & PREVENTION, 2025, 37
  • [24] Qualitative study of Stroke Survivors' Perceptions of Secondary Prevention
    Lin, Beilei
    Zhang, Zhenxiang
    Thrift, Amanda G.
    Wang, Wenna
    Mei, Yongxia
    Guo, Yunfei
    Liu, Lamei
    Liu, Fang
    Xue, Lihong
    JOURNAL OF ADVANCED NURSING, 2022, 78 (05) : 1377 - 1388
  • [25] Responding to social needs and financial barriers to improve medication adherence in primary care
    Drake, C.
    Lian, T.
    Eisenson, H.
    Zullig, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 304 - 304
  • [26] Explanatory models of depression and treatment adherence to antidepressant medication: A qualitative interview study
    Buus, Niels
    Johannessen, Helle
    Stage, Kurt Bjerregaard
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2012, 49 (10) : 1220 - 1229
  • [27] The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
    Mostafavi, Firoozeh
    Alavijeh, Fereshteh Zamani
    Salahshouri, Arash
    Mahaki, Behzad
    BIOPSYCHOSOCIAL MEDICINE, 2021, 15 (01)
  • [28] Barriers and Facilitators of Medication Adherence Among Minority SLE Patients: A Qualitative Study
    Sun, Kai
    Dombeck, Carrie
    Swezey, Teresa
    Corneli, Amy
    Eudy, Amanda
    Sadun, Rebecca
    Rogers, Jennifer
    Criscione-Schreiber, Lisa
    Doss, Jayanth
    Clowse, Megan
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] Qualitative Study of Barriers to Adherence to Antihypertensive Medication among Rural Women in India
    Gupta, Shreya
    Dhamija, Jas Pal
    Mohan, Indu
    Gupta, Rajeev
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2019, 2019
  • [30] Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study
    Meng, Yuki
    Chiu, Christopher
    Kapoor, Mamta
    Li, Shelly-Anne
    Kaur, Navaldeep
    Marr, Patricia
    Kwan, Debbie
    Leblanc, Kori
    Ji, Catherine
    Papoushek, Christine
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15